"How pharma keeps a trove of drug trials out of public view"

The Washington Post's Wonkblog reports today on a new study. The study's authors found that a third of the clinical trial results that federal regulators reviewed to approve drugs made by large pharmaceutical companies in 2012 were never publicly reported.

The full article is here.